國立高雄大學圖資館 |

Language: English

Back

New insights on antiviral probiotics...

Kassaa, Imad Al.

New insights on antiviral probioticsfrom research to applications /

Record Type:	Electronic resources : Monograph/item
Title/Author:	New insights on antiviral probioticsby Imad Al Kassaa.
Reminder of title:	from research to applications /
Author:	Kassaa, Imad Al.
Published:	Cham :Springer International Publishing :2017.
Description:	xii, 119 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
Subject:	Antiviral agents.
Online resource:	http://dx.doi.org/10.1007/978-3-319-49688-7
ISBN:	9783319496887$q(electronic bk.)

New insights on antiviral probioticsfrom research to applications /
Kassaa, Imad Al.

New insights on antiviral probioticsfrom research to applications /[electronic resource] :by Imad Al Kassaa. - Cham :Springer International Publishing :2017. - xii, 119 p. :ill., digital ;24 cm.

Antiviral probiotics: a new concept in medical sciences -- The use of probiotics as vaccine vectors to prevent viral infections -- Probiotics: Role in the prevention of chronic viral diseases -- The antiviral activity of probiotic metabolites -- Methods and techniques to evaluate the antiviral activity of a new probiotic strain.

This book focuses on probiotics with antiviral activities. The "antiviral probiotic" is a new concept in medical sciences. Recently, studies have shown that antiviral probiotics can fight or prevent viral infections in many ways. The immunomodulation of mucosal immunity, production of antiviral compounds, virus trapping and the use thereof as vaccination vectors are the principal modes of action of antiviral probiotics. The author dedicates an entire chapter of the book to discussing the methods and techniques used to assess the antiviral activity of probiotic strains and their metabolites.

ISBN: 9783319496887$q(electronic bk.)

Standard No.: 10.1007/978-3-319-49688-7doiSubjects--Topical Terms:

229449
Antiviral agents.

LC Class. No.: RM666.P835

Dewey Class. No.: 615.329

New insights on antiviral probioticsfrom research to applications /
LDR:01884nmm a2200313 a 4500 001 506063
003 DE-He213
005 20161201074250.0
006 m d
007 cr nn 008maaau
008 171030s2017 gw s 0 eng d
020 $a 9783319496887$q(electronic bk.)
020 $a 9783319496870$q(paper)
024 7 $a 10.1007/978-3-319-49688-7 $2 doi
035 $a 978-3-319-49688-7
040 $a GP $c GP
041 0 $a eng
050 4 $a RM666.P835
072 7 $a PSG $2 bicssc
072 7 $a SCI045000 $2 bisacsh
082 0 4 $a 615.329 $2 23
090 $a RM666.P835 $b K19 2017
100 1 $a Kassaa, Imad Al. $3 771830
245 1 0 $a New insights on antiviral probiotics $h [electronic resource] : $b from research to applications / $c by Imad Al Kassaa.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2017.
300 $a xii, 119 p. : $b ill., digital ; $c 24 cm.
505 0 $a Antiviral probiotics: a new concept in medical sciences -- The use of probiotics as vaccine vectors to prevent viral infections -- Probiotics: Role in the prevention of chronic viral diseases -- The antiviral activity of probiotic metabolites -- Methods and techniques to evaluate the antiviral activity of a new probiotic strain.
520 $a This book focuses on probiotics with antiviral activities. The "antiviral probiotic" is a new concept in medical sciences. Recently, studies have shown that antiviral probiotics can fight or prevent viral infections in many ways. The immunomodulation of mucosal immunity, production of antiviral compounds, virus trapping and the use thereof as vaccination vectors are the principal modes of action of antiviral probiotics. The author dedicates an entire chapter of the book to discussing the methods and techniques used to assess the antiviral activity of probiotic strains and their metabolites.
650 0 $a Antiviral agents. $3 229449
650 0 $a Probiotics. $3 356934
650 1 4 $a Life Sciences. $3 273679
650 2 4 $a Microbiology. $3 192943
650 2 4 $a Virology. $3 196498
650 2 4 $a Immunology. $3 189152
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-49688-7
950 $a Biomedical and Life Sciences (Springer-11642)